Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Zentek Ltd.NASDAQ: ZTEK

Revenue · Q4 FY2025 · quarter ended Mar 2026

Revenue declines year over year

Q4 FY2025 revenue of CA$36.86K fell 95.5% year over year, behind the -81.0% change in trailing-twelve-month revenue. Sequentially, it fell 43.5% from the prior quarter. Over 3 fiscal years it compounded at +31.7% a year.

Context

  • Revenue increased in 1 of the last 3 fiscal years.

What to watch

Whether revenue reaches the consensus estimate from 1 analysts of CA$117.14K (-29.6%) for the fiscal year ending Mar 2027, a step up from the -80.9% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$36.86K-43.5% QoQ
Last fiscal yearMar 2026
CA$166.48K-80.9% YoY
LTMMar 2026
CA$166.09K-81.0% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-95.5%+489.5%+585.0 pp
1 year-80.9%-29.6%+51.3 pp
3-year CAGR+31.7%+89.7%+57.9 pp
5-year CAGR+145.0%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

CAD · from the income statement

Latest · FY2025
166.48K CAD
Year-over-year change
-80.9%
4-year CAGR
-16.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How ZTEK compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -81.0% is the 5th highest of 6, against a peer median of +3.3%.
  • Over three fiscal years its annual growth of +31.7% compares with a peer median of +8.2%.
ZTEK Competitors
Revenue for ZTEK and competitors
Company Period LTM YoY 3-year CAGR
AMWLAmerican Well CorporationLTM Mar 2026$237.38M USD-9.3%-3.5%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$18.36M CAD+3.3%+8.2%
HYPRHyperfine, Inc.LTM Mar 2026$15.33M USD+30.7%+25.8%
ZTEKZentek Ltd.LTM Mar 2026CA$166.09K CAD-81.0%+31.7%
MBOTMicrobot Medical Inc.LTM Mar 2026$105K USD——
ALXOALX Oncology Holdings Inc.LTM Mar 2026$0 USD——
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$0 CAD——
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD-100.0%—
BYSIBeyondSpring Inc.LTM Mar 2026$0 USD+100.0%—
Peer median (excluding ZTEK) —+3.3%+8.2%

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue339.67K72.86K29.82K872.5K166.48K
Cost of Revenue376.79K853.34K331.08K680.01K6.47M
Gross Profit(37.12K)(780.48K)(301.26K)192.49K(6.3M)
Gross Margin-10.9%-1071.3%-1010.4%22.1%-3785.5%
Research & Development1.54M1.65M1.78M465.65K1.66M
Selling, General & Admin9.56M10.99M8.95M8.01M2.87M
Operating Expenses12.53M13.87M11.68M9.79M4.56M
Depreciation & Amortization614.71K539.69K613.71K600.32K527.77K
EBITDA(31.02M)(13.75M)(11.08M)(9.35M)(10.33M)
EBITDA Margin-9131.2%-18878.5%-37170.3%-1071.4%-6204.7%
Operating Income(12.56M)(14.65M)(11.98M)(9.6M)(10.86M)
Operating Margin-3698.5%-20112.5%-40174.8%-1100.4%-6521.7%
Interest Income20.6K510.26K405.48K101.61K40.41K
Interest Expense63.78K120.62K107.37K91.32K289.98K
Other Income / Expenses(19.13M)238.68K174.74K(439.03K)1.06M
Income Before Tax(31.69M)(14.41M)(11.8M)(10.04M)(9.79M)
Pre-Tax Margin-9330.9%-19784.9%-39588.7%-1150.7%-5882.6%
Income Tax Expense00(99.78K)00
Net Income(31.69M)(14.41M)(11.7M)(10.04M)(9.79M)
Net Margin-9330.9%-19784.9%-39254.1%-1150.7%-5882.6%
EPS (Basic)(0.42)(0.14)(0.12)(0.10)(0.09)
EPS (Diluted)(0.42)(0.14)(0.12)(0.10)(0.09)
Weighted Avg Shares92.09M99.44M97.53M102.98M105.92M
Weighted Avg Shares (Diluted)92.09M99.44M100.5M102.98M105.92M

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.